{"id":950113,"date":"2026-04-09T07:05:53","date_gmt":"2026-04-09T11:05:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/"},"modified":"2026-04-09T07:05:53","modified_gmt":"2026-04-09T11:05:53","slug":"definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/","title":{"rendered":"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistcircle { list-style-type: circle }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Definium Therapeutics to Participate at Upcoming Investor Conferences and Events<\/b><\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nDefinium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company\u2019s management team will participate in the following investor conferences and events:<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>25<sup>th <\/sup>Annual Needham Virtual Healthcare Conference<\/b>\n<ul class=\"bwlistcircle\">\n<li>\nFireside Chat Date and Time: Thursday, April 16, 2026 at 3:00 PM EDT<\/p>\n<\/li>\n<li>\nWebcast Link: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fevent.summitcast.com%2Fview%2FcCMfZsH5ZqrwSNTwfC9JDv%2FEtvPxEN8amMREtEyiZrqPS&amp;esheet=54486262&amp;newsitemid=20260409979642&amp;lan=en-US&amp;anchor=25th+Annual+Needham+Virtual+Healthcare+Conference&amp;index=1&amp;md5=d869380b24c70cdd3883e02db077d75c\">25<sup>th<\/sup> Annual Needham Virtual Healthcare Conference<\/a><\/li>\n<\/ul>\n<\/li>\n<li><b>Definium Therapeutics Investor &amp; Analyst Day<\/b>\n<ul class=\"bwlistcircle\">\n<li>\nDate and Time: Wednesday, April 22, 2026 from 10:00 AM \u2013 12:00 PM EDT (followed by lunch)<\/p>\n<\/li>\n<li>\nLocation: Well&amp; by Durst, 151 W 42nd St, New York, NY 10036<\/p>\n<\/li>\n<li>\nRegistration Link (in person and virtual*): <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdefinium-therapeutics-investor-analyst-day-2026.open-exchange.net%2F&amp;esheet=54486262&amp;newsitemid=20260409979642&amp;lan=en-US&amp;anchor=Definium+Therapeutics+Investor+%26amp%3B+Analyst+Day&amp;index=2&amp;md5=a16d46cc0ba6e7bb4b0e4b5880e5faa6\">Definium Therapeutics Investor &amp; Analyst Day<br \/>\n<\/a><br \/><i>*In-person attendance is limited to invited research analysts and institutional investors.<\/i><\/li>\n<\/ul>\n<\/li>\n<li><b>Needham Virtual Psychedelics Forum<\/b>\n<ul class=\"bwlistcircle\">\n<li>\nPanel: Clinical Risk, Regulatory Reality and the Path to Scale<\/p>\n<\/li>\n<li>\nDate and Time: Monday, April 27, 2026 at 11:00 AM EDT<br \/>\n<br \/><i>Please contact your Needham representative for access to the panel presentation.<\/i><\/li>\n<\/ul>\n<\/li>\n<li><b>2026 RBC Capital Markets Global Healthcare Conference<\/b>\n<ul class=\"bwlistcircle\">\n<li>\nDate and Time: Tuesday, May 19, 2026 at 8:00 AM EDT<\/p>\n<\/li>\n<li>\nLocation: New York, NY<\/p>\n<\/li>\n<li>\nWebcast Link: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fdefinium-therapeutics-inc-may-2026&amp;esheet=54486262&amp;newsitemid=20260409979642&amp;lan=en-US&amp;anchor=2026+RBC+Capital+Markets+Global+Healthcare+Conference&amp;index=3&amp;md5=905c9b5538606917db24320adff42036\">2026 RBC Capital Markets Global Healthcare Conference<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\nAudio webcasts and replays of available presentations will be accessible on Definium\u2019s <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.definiumtx.com%2Fnews-events%2Fir-calendar&amp;esheet=54486262&amp;newsitemid=20260409979642&amp;lan=en-US&amp;anchor=Investor+Relations&amp;index=4&amp;md5=8c48cd22a29e1e0e5c3af175b30dbdd8\">Investor Relations<\/a> website for up to 90 days following each event.<\/p>\n<p><b>About Definium Therapeutics<\/b><\/p>\n<p>\nThe mission of Definium Therapeutics is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Guided by a recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today\u2019s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.<\/p>\n<p>\nFor more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdefiniumtx.com%2F&amp;esheet=54486262&amp;newsitemid=20260409979642&amp;lan=en-US&amp;anchor=https%3A%2F%2Fdefiniumtx.com%2F&amp;index=5&amp;md5=13f854c2958590aa042d5171f2090b07\">https:\/\/definiumtx.com\/<\/a> and follow Definium Therapeutics on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2FVlmTC82oMRF4jPoQH1h5Hy6_iR%3Fdomain%3Dinstagram.com%2F&amp;esheet=54486262&amp;newsitemid=20260409979642&amp;lan=en-US&amp;anchor=Instagram&amp;index=6&amp;md5=471ad5a9c3e518fdaf0ac375649cf3ed\">Instagram<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2FwrNVC9rpDVI7mNGxU3iqHqBfl3%3Fdomain%3Dlinkedin.com&amp;esheet=54486262&amp;newsitemid=20260409979642&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=7&amp;md5=c8ec716207f332f46232fbf7a5b410c1\">LinkedIn<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2F89p4C0R20JIP2g14fWsvH9IYFd%3Fdomain%3Dx.com&amp;esheet=54486262&amp;newsitemid=20260409979642&amp;lan=en-US&amp;anchor=X&amp;index=8&amp;md5=47e9ce7c7dc7b1aa5371e6f180c52eae\">X<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260409979642\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260409979642\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>Gitanjali Jain<br \/>\n<br \/>VP, Head of Investor Relations<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@definiumtx.com\">ir@definiumtx.com<\/a><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/><a rel=\"nofollow\" href=\"mailto:media@definiumtx.com\">media@definiumtx.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New York United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Mental Health Health Neurology Clinical Trials Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260409979642\/en\/2768998\/3\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Definium Therapeutics to Participate at Upcoming Investor Conferences and Events NEW YORK&#8211;(BUSINESS WIRE)&#8211; Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company\u2019s management team will participate in the following investor conferences and events: 25th Annual Needham Virtual Healthcare Conference Fireside Chat Date and Time: Thursday, April 16, 2026 at 3:00 PM EDT Webcast Link: 25th Annual Needham Virtual Healthcare Conference Definium Therapeutics Investor &amp; Analyst Day Date and Time: Wednesday, April 22, 2026 from 10:00 AM \u2013 12:00 PM EDT (followed by lunch) Location: Well&amp; by Durst, 151 W 42nd St, New York, NY 10036 Registration &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Definium Therapeutics to Participate at Upcoming Investor Conferences and Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-950113","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Definium Therapeutics to Participate at Upcoming Investor Conferences and Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events NEW YORK&#8211;(BUSINESS WIRE)&#8211; Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company\u2019s management team will participate in the following investor conferences and events: 25th Annual Needham Virtual Healthcare Conference Fireside Chat Date and Time: Thursday, April 16, 2026 at 3:00 PM EDT Webcast Link: 25th Annual Needham Virtual Healthcare Conference Definium Therapeutics Investor &amp; Analyst Day Date and Time: Wednesday, April 22, 2026 from 10:00 AM \u2013 12:00 PM EDT (followed by lunch) Location: Well&amp; by Durst, 151 W 42nd St, New York, NY 10036 Registration &hellip; Continue reading &quot;Definium Therapeutics to Participate at Upcoming Investor Conferences and Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-09T11:05:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events\",\"datePublished\":\"2026-04-09T11:05:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/\"},\"wordCount\":392,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/\",\"name\":\"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-04-09T11:05:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/","og_locale":"en_US","og_type":"article","og_title":"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events - Market Newsdesk","og_description":"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events NEW YORK&#8211;(BUSINESS WIRE)&#8211; Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company\u2019s management team will participate in the following investor conferences and events: 25th Annual Needham Virtual Healthcare Conference Fireside Chat Date and Time: Thursday, April 16, 2026 at 3:00 PM EDT Webcast Link: 25th Annual Needham Virtual Healthcare Conference Definium Therapeutics Investor &amp; Analyst Day Date and Time: Wednesday, April 22, 2026 from 10:00 AM \u2013 12:00 PM EDT (followed by lunch) Location: Well&amp; by Durst, 151 W 42nd St, New York, NY 10036 Registration &hellip; Continue reading \"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-09T11:05:53+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events","datePublished":"2026-04-09T11:05:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/"},"wordCount":392,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/","name":"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-04-09T11:05:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409979642r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Definium Therapeutics to Participate at Upcoming Investor Conferences and Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=950113"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950113\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=950113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=950113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=950113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}